Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lydia Visser

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Haematologica|December 20, 2011
Expression of the c-Met oncogene by tumor cells predicts a favorable outcome in classical Hodgkin's lymphomaChuanhui Xu, Wouter Plattel, Anke van den Berg, et al.
The American Journal of Pathology|February 20, 2018
Argonaute 2 RNA Immunoprecipitation Reveals Distinct miRNA Targetomes of Primary Burkitt Lymphoma Tumors and Normal B CellsAgnieszka Dzikiewicz-Krawczyk, Arjan Diepstra, Bea Rutgers, et al.
The American Journal of Pathology|July 18, 2016
Long Noncoding RNA Expression Profiling in Normal B-Cell Subsets and Hodgkin Lymphoma Reveals Hodgkin and Reed-Sternberg Cell-Specific Long Noncoding RNAsMina Masoumeh Tayari, Melanie Winkle, Gertrud Kortman, et al.
Frontiers in Oncology|March 21, 2020
B Cells as Prognostic Biomarker After Surgery for Colorectal Liver MetastasesJoost Hof, Lydia Visser, Diederik J Höppener, et al.
Blood Cancer Journal|March 8, 2022
Identification of the estrogen receptor beta as a possible new tamoxifen-sensitive target in diffuse large B-cell lymphomaMyra Langendonk, Mathilde R W de Jong, Nienke Smit, et al.
Behavioural Brain Research|October 21, 2009
Methotrexate reduces hippocampal blood vessel density and activates microglia in rats but does not elevate central cytokine releaseRiejanne Seigers, Jessica Timmermans, Hans J van der Horn, et al.
Molecules (Basel, Switzerland)|December 24, 2021
Genetic Modification Approaches for Parasporins <i>Bacillus thuringiensis</i> Proteins with Anticancer ActivityMiguel O Suárez-Barrera, Lydia Visser, Paola Rondón-Villarreal, et al.
Blood|December 12, 2007
Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytesYue Ma, Lydia Visser, Han Roelofsen, et al.
Plos One|March 1, 2018
Identification of relevant drugable targets in diffuse large B-cell lymphoma using a genome-wide unbiased CD20 guilt-by association approachMathilde R W de Jong, Lydia Visser, Gerwin Huls, et al.
Blood|July 17, 2007
HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphomaMarijke Niens, Ruth F Jarrett, Bouke Hepkema, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Haematologica|December 20, 2011
Expression of the c-Met oncogene by tumor cells predicts a favorable outcome in classical Hodgkin's lymphomaChuanhui Xu, Wouter Plattel, Anke van den Berg, et al.
The American Journal of Pathology|February 20, 2018
Argonaute 2 RNA Immunoprecipitation Reveals Distinct miRNA Targetomes of Primary Burkitt Lymphoma Tumors and Normal B CellsAgnieszka Dzikiewicz-Krawczyk, Arjan Diepstra, Bea Rutgers, et al.
The American Journal of Pathology|July 18, 2016
Long Noncoding RNA Expression Profiling in Normal B-Cell Subsets and Hodgkin Lymphoma Reveals Hodgkin and Reed-Sternberg Cell-Specific Long Noncoding RNAsMina Masoumeh Tayari, Melanie Winkle, Gertrud Kortman, et al.
Frontiers in Oncology|March 21, 2020
B Cells as Prognostic Biomarker After Surgery for Colorectal Liver MetastasesJoost Hof, Lydia Visser, Diederik J Höppener, et al.
Blood Cancer Journal|March 8, 2022
Identification of the estrogen receptor beta as a possible new tamoxifen-sensitive target in diffuse large B-cell lymphomaMyra Langendonk, Mathilde R W de Jong, Nienke Smit, et al.
Behavioural Brain Research|October 21, 2009
Methotrexate reduces hippocampal blood vessel density and activates microglia in rats but does not elevate central cytokine releaseRiejanne Seigers, Jessica Timmermans, Hans J van der Horn, et al.
Molecules (Basel, Switzerland)|December 24, 2021
Genetic Modification Approaches for Parasporins <i>Bacillus thuringiensis</i> Proteins with Anticancer ActivityMiguel O Suárez-Barrera, Lydia Visser, Paola Rondón-Villarreal, et al.
Blood|December 12, 2007
Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytesYue Ma, Lydia Visser, Han Roelofsen, et al.
Plos One|March 1, 2018
Identification of relevant drugable targets in diffuse large B-cell lymphoma using a genome-wide unbiased CD20 guilt-by association approachMathilde R W de Jong, Lydia Visser, Gerwin Huls, et al.
Blood|July 17, 2007
HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphomaMarijke Niens, Ruth F Jarrett, Bouke Hepkema, et al.
Pageof 8